PubMed

Effects of losartan in hypertension without vascular disease.

Messerli FH.

Ann Intern Med. 2004 Apr 6;140(7):W29. No abstract available. PMID: 15069010 [PubMed - indexed for MEDLINE]Related articlesFree article

Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.

Fuchs FD.

Lancet. 2002 Jun 22;359(9324):2203; author reply 2203-4. No abstract available. PMID: 12091010 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Benefits of losartan in patients with hypertension and left ventricular hypertrophy but no vascular disease.

[No authors listed]

Ann Intern Med. 2003 Aug 5;139(3):I28. No abstract available. PMID: 12899605 [PubMed - indexed for MEDLINE]Related articlesFree article

Losartan vs atenolol in prevention of stroke and cardiovascular disease.

Fournier A, Oprisiu R, Andrejak M, Fernandez L, Achard JM.

JAMA. 2003 Feb 12;289(6):700; author reply 701. No abstract available. PMID: 12585946 [PubMed - indexed for MEDLINE]Related articles

Losartan vs atenolol in prevention of stroke and cardiovascular disease.

Messerli FH, Grossman E, Fournier A.

JAMA. 2003 Feb 12;289(6):700-1; author reply 701. No abstract available. PMID: 12585945 [PubMed - indexed for MEDLINE]Related articles

The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.

Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Lyle PA, Nieminen MS.

J Hum Hypertens. 2006 Jun;20(6):460-4. No abstract available. PMID: 16572193 [PubMed - indexed for MEDLINE]Related articles

[The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study]

Ibsen H, Lindholm LH, Pedersen OL, Dahlöf B, Kjeldsen S.

Ugeskr Laeger. 2003 Jan 27;165(5):459-62. Danish. PMID: 12599844 [PubMed - indexed for MEDLINE]Related articles

Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.

Hamon M.

Lancet. 2002 Jun 22;359(9324):2199-200; author reply 2203-4. No abstract available. PMID: 12091003 [PubMed - indexed for MEDLINE]Related articles

Pulse pressure and antihypertensive agents.

Safar ME, O'Rourke MF.

Hypertension. 2005 Aug;46(2):e6; author reply e6-7. Epub 2005 Jul 18. No abstract available. PMID: 16027242 [PubMed - indexed for MEDLINE]Related articlesFree article

The LIFE Trial in 2004.

Beevers DG.

J Hum Hypertens. 2004 Jun;18(6):365. No abstract available. PMID: 15153931 [PubMed - indexed for MEDLINE]Related articles

Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.

Cruickshank JM.

Lancet. 2002 Jun 22;359(9324):2200-1; author reply 2203-4. No abstract available. PMID: 12091004 [PubMed - indexed for MEDLINE]Related articles

[Kidney protection leads to heart protection, too]

[No authors listed]

MMW Fortschr Med. 2006 Aug 17;148(33-34):57. German. No abstract available. PMID: 16981393 [PubMed - indexed for MEDLINE]Related articles

[Results from the LIFE study: promising effects of new hypertensive agents]

Nilsson P, Kahan T.

Lakartidningen. 2002 Apr 18;99(16):1792-4. Review. Swedish. No abstract available. PMID: 12043477 [PubMed - indexed for MEDLINE]Related articles

[Angiotensin 1-antagonists: primary therapeutic option in arterial hypertension, too]

Traut.

Dtsch Med Wochenschr. 2003 Jan 24;128(4):161; discussion 161-2. German. No abstract available. PMID: 12589590 [PubMed - indexed for MEDLINE]Related articles

[Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker]

[No authors listed]

MMW Fortschr Med. 2003 May 8;145(19):53. German. No abstract available. PMID: 12813983 [PubMed - indexed for MEDLINE]Related articles

Might losartan reduce sudden cardiac death in diabetic patients with hypertension?

Aronow WS.

Lancet. 2003 Aug 23;362(9384):591-2. No abstract available. PMID: 12944056 [PubMed - indexed for MEDLINE]Related articles

[Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"]

[No authors listed]

MMW Fortschr Med. 2002 Sep 19;144(38):14. German. No abstract available. PMID: 12395694 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB.

J Am Coll Cardiol. 2005 Mar 1;45(5):705-11.PMID: 15734614 [PubMed - indexed for MEDLINE]Related articles

[To protect the hypertensive patient from complications. Blood pressure lowering is not equal to blood pressure lowering]

[No authors listed]

MMW Fortschr Med. 2003 Nov 6;145(45):51. German. No abstract available. PMID: 14712789 [PubMed - indexed for MEDLINE]Related articles

Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.

Cockcroft JR, Brown MJ.

Lancet. 2002 Jun 22;359(9324):2202; author reply 2203-4. No abstract available. PMID: 12091008 [PubMed - indexed for MEDLINE]Related articles